4//SEC Filing
Biller Jonathan 4
Accession 0000875320-24-000047
CIK 0000875320other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:56 PM ET
Size
6.6 KB
Accession
0000875320-24-000047
Insider Transaction Report
Form 4
Biller Jonathan
EVP and Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2024-02-09$422.74/sh−1,588$671,311→ 20,018 total - Sale
Common Stock
2024-02-12$418.77/sh−1,738$727,822→ 18,280 total
Footnotes (3)
- [F1]Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2023.
- [F2]Mr. Biller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $418.77 (range $418.76 to $418.82).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001744749
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:56 PM ET
- Size
- 6.6 KB